Latest AKTX reports update at 2024-06-01: 2024-Q12023-Q42023-Q1
Akari Therapeutics, Plc logo
Akari Therapeutics, Plc AKTX
$ 3.12 2.3%

Akari Therapeutics, Plc EV/EBITDA Ratio 2011-2024 | AKTX

Annual EV/EBITDA Ratio Akari Therapeutics, Plc

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-249 -245 -195 -154 -94.8 -293 -219 -2.47 -3.79 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.47 -293 -162